Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bringing Out the Usual – and Unusual – Cancer Genomics Suspects

Published: Tuesday, June 18, 2013
Last Updated: Tuesday, June 18, 2013
Bookmark and Share
Several years ago, researchers sequencing lung cancer genomes encountered a number of red herrings.

After combing through thousands of genes in a large number of patients, they had come up with a list of likely genetic suspects tied to the disease. Most of these genes made sense – some had previously been implicated in cancer, others clearly played an important biological role. But the data also pointed to a group of genes encoding olfactory receptors – the proteins that allow us to smell. Why were so many of these genes cropping up? Could these possibly be culprit genes? In the end, researchers found that they were simply red herrings – distractions along the way to pinpointing the mutations driving cancer.

As cancer genomics scales up, more and more mutations can be detected. But in order for critical patterns and potential drug targets to emerge, researchers need to be able to eliminate the red herrings from their results and identify the genetic changes driving different cancer types. To do so, Broad researchers have surveyed the genetic landscape of cancer to better understand the spectrum of mutations within and across cancer types, and have used this information to develop a more sophisticated analytical methodology to detect key mutations. Known as MutSigCV, the new methodology is featured prominently in a paper appearing in Nature this week.

“Back in the days when there was very little data, researchers would get excited about seeing one mutation in a gene,” said co-first author Michael Lawrence, a Broad computational biologist. “But in this era of big data, thousands of samples are being sequenced and every gene has many mutations. We have to be able to support the idea that the mutation rate of a particular gene is above what we’d expect to see.”

Lawrence and his colleagues wanted to understand the source of the red herring problem. Most analytical approaches used for finding cancer genes take into account the overall genome-wide mutation frequency in a given type of cancer as well as a handful of other parameters. But these measures are often not enough to weed out unhelpful results. Mutations are not uniform across the genome, and some genes are ‘highly mutable,’ meaning that for a variety of reasons, they are more prone to accumulating mutations.

“Not taking these highly mutable genetic regions into account leads to declaring that genes in these regions have more mutations than expected and therefore likely were positively selected for during the cancer’s evolution,” said senior author Gad Getz, director of Cancer Genome Computational Analysis at the Broad. “Now we know that this could have been just by chance so there is really no evidence that these genes are actually involved in cancer.”

In order to factor in these highly mutable genes and other sources of problematic data, Getz’s team developed an algorithm that takes context into account. Any given nucleotide in the genome is influenced by three major kinds of context: its immediate, DNA neighbors (having an A, C, T, or G on either side); its location on a chromosome; and the type of cell it is in.

In the case of the olfactory receptor genes that kept turning up unexpectedly in the lung cancer data, a key clue would emerge when a visiting scientist named Paz Polak gave a talk to Getz’s lab. His talk had to do with the phenomenon of DNA replication timing. In order for a cell to divide and each daughter cell to receive a complete copy of the genome, all of the DNA must be duplicated. But this copying process does not happen all at once – some genes get copied early, and others are copied later (this animation shows the process over time). Genes that get copied later tend to be more prone to mutation. And olfactory receptor genes tend to get copied quite late.

“That was the real key to solving this mystery,” said Lawrence. “We went back to our data and looked at the olfactory receptors, and sure enough, they are uniformly late replicating.”

Using this criterion and many others, the researchers developed MutSigCV to account for context when ranking the most promising genetic findings. By looking at data from over 3,000 tumor samples representing 27 cancer types, the team was able to see the extraordinary range of mutation frequency and spectrum for tumors.

These maps show patterns that are unique to certain cancer types. For instance, skin cancer has a specific pattern or “signature” that reflects mutations induced by ultraviolet light; lung cancer’s signature is influenced by tobacco smoke; and other cancers – head and neck cancer, cervical cancer, and bladder cancer – all share a common signature likely tied to a response to infection.

Overall, the frequency of mutations varied by more than 1,000 fold between cancers with the lowest (pediatric cancers and leukemias) and the highest (melanoma and lung cancer) mutation rates.

With the ability to eliminate many suspicious genes, the researchers say it is now possible to start analyzing large cancer collections, including combined datasets from many cancer types. “We believe that this tool should be used in all studies — small or large — since the resulting gene list more accurately represents genes that have undergone positive selection in cancer,” said Getz. “Our goal is to use MutSigCV across cancer datasets to get the most comprehensive list of cancer genes.”

By combining MutSigCV with other MutSig tools, Getz’s team has already begun undertaking this challenge, looking across cancer types in what his group refers to as “pan-cancer” studies. Through this work, they hope to pinpoint genes that transcend cancer type and offer promising targets for drug treatment for many patients.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Broad Institute & Google Genomics Combine Bioinformatics and Computing Expertise
Both companies explore how to break down major technical barriers that increasingly hinder biomedical research.
Thursday, June 25, 2015
CRISP-Disp Leverages CRISPR-Cas9 to Deliver RNA Structures to Targets in the Genome
A team of researchers from the Broad Institute and the Harvard Stem Cell Institute has developed CRISP-Disp, a method that expands on the CRISPR-Cas9 system, allowing researchers to display multiple, large RNA structures on the Cas9 protein.
Wednesday, June 10, 2015
GTEx: Useful Expression For Cancer Research
GTEx Project has recently published several papers reporting on findings from its two-year pilot phase.
Tuesday, May 26, 2015
Single-cell Analysis Hits its Stride
Advances in technology and computational analysis enable scale and affordability, paving the way for translational studies.
Saturday, May 23, 2015
Highly Efficient New Cas9 for In Vivo Genome Editing
New finding is expected to expand therapeutic and experimental applications of CRISPR.
Tuesday, April 07, 2015
Broad Institute of MIT and Harvard and Bayer Healthcare Expand their Partnership
Collaboration to develop therapies for cardiovascular disease.
Thursday, April 02, 2015
In vivo CRISPR-Cas9 Screen Sheds Light On Cancer Metastasis And Tumor Evolution
Genome-scale study points to drivers of tumor evolution and metastasis, provides roadmap for future in vivo Cas9 screens.
Friday, March 06, 2015
Scientists Map the Human Loop-ome, Revealing a New Form of Genetic Regulation
Researchers describe the results of a five-year effort to map, in unprecedented detail, how the 2-meter long human genome folds inside the nucleus of a cell.
Tuesday, December 23, 2014
Disorder in Gene-Control System is a Defining Characteristic of Cancer, Study Finds
Findings indicate that the disarray in the on-off mechanism is one of the defining characteristics of cancer.
Tuesday, December 23, 2014
Two Studies Identify A Detectable, Pre-Cancerous State In The Blood
Findings pave way for new lines of cancer research focused on detection and prevention.
Thursday, November 27, 2014
Dramatic Response And Resistance To Cancer Drug Traced
Sequencing reveals why thyroid tumor responded to, and eventually resisted, treatment.
Friday, October 10, 2014
Study Expands the Cancer Genomics Universe
The universe of cancer mutations is much bigger than previously thought, and key cancer genes are still to be discovered.
Tuesday, January 28, 2014
Predicting Cancer’s Next Move
Research offers a new approach to studying drug resistance in cancer.
Monday, November 11, 2013
Mexico-US Genomics Partnership Launches Second Phase
SIGMA 2 is aimed at harnessing genomic medicine for the benefit of Latin America and the world.
Wednesday, October 30, 2013
Understanding Triglycerides’ Role in Coronary Disease
The study leverages new genetic data from a related genome-wide association study, suggests that lowering triglyceride levels through treatment may help reduce the risk of coronary heart disease.
Wednesday, October 09, 2013
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Toxin from Salmonid Fish has Potential to Treat Cancer
Researchers from the University of Freiburg decode molecular mechanism of fish pathogen.
Study Finds Non-Genetic Cancer Mechanism
Cancer can be caused solely by protein imbalances within cells, a study of ovarian cancer has found.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Mystery of the Instant Noodle Chromosomes
Researchers from the Lomonosov Moscow State University evaluated the benefits of placing the DNA on the principle of spaghetti.
Oxitec ‘Self-Limiting Gene’ Offers Hope for Controlling Invasive Moth
A new pesticide-free and environmentally-friendly way to control insect pests has moved ahead with the publication of results showing that Oxitec diamondback moths (DBM) with a ‘self-limiting gene’ can dramatically reduce populations of DBM.
Web App Helps Researchers Explore Cancer Genetics
Brown University computer scientists have developed a new interactive tool to help researchers and clinicians explore the genetic underpinnings of cancer.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!